Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2026 ,inter alia, to consider and approve 1.Approval of the Audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sandu Pharmaceuticals Ltd has informed BSE about a board meeting scheduled for May 5, 2026. The meeting agenda includes, inter alia, consideration and approval of audited financial statements. The document content is truncated and the full details of the agenda items are not visible. This appears to be a routine board meeting for approval of annual/financial results. The actual BSE filing page shows an error message, limiting the availability of complete information.
This is a routine event for listed companies - approval of audited results is standard practice. No specific impact can be assessed without access to the actual financial data or complete agenda details. Shareholders should await the actual results announcement for meaningful insights.